Evidence map›Paper›PMID 28361098›Full record

ArticleMolecular genetics & genomic medicine2017

Building a family network from genetic testing.

Kathleen A Leppig, Heidi A Thiese, David Carrel, David R Crosslin, Michael O Dorschner, Adam S Gordon, Andrea Hartzler, James Ralston, Aaron Scrol, Eric B Larson and 1 more

Open access · goldAbstract read
In one paragraph

Article in Molecular genetics & genomic medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact, top 87% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. A systematic literature review of disclosure practices and reported outcomes for medically actionable genomic secondary findings.Genetics in medicine : official journal of the American College of Medical Genetics · 2021
    Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Kathleen A LeppigGenetic ServicesGroup Health CooperativeSeattleWA98112USA; Department of PathologyUniversity of WashingtonSeattleWA98195USA.
Heidi A ThieseGenetic Services Group Health Cooperative Seattle WA 98112 USA.
David CarrelGroup Health Research Institute Group Health Cooperative Seattle WA 98101 USA.
David R CrosslinDepartment of Biomedical Informatics and Medical Education University of Washington Seattle WA 98195 USA.
Michael O DorschnerDepartment of Pathology University of Washington Seattle WA 98195 USA.
Adam S GordonDepartment of Medicine (Medical Genetics) and Genomic Sciences University of Washington Seattle WA 98195 USA.
Andrea HartzlerGroup Health Research Institute Group Health Cooperative Seattle WA 98101 USA.
James RalstonGroup Health Research Institute Group Health Cooperative Seattle WA 98101 USA.
Aaron ScrolGroup Health Research Institute Group Health Cooperative Seattle WA 98101 USA.
Eric B LarsonGroup Health Research Institute Group Health Cooperative Seattle WA 98101 USA.
Gail P JarvikDepartment of Medicine (Medical Genetics) and Genomic Sciences University of Washington Seattle WA 98195 USA.
Group Health Cooperative · USUniversity of Washington Medical Center · USKaiser Permanente Washington Health Research Institute · USUniversity of Washington · US

Funding

Variation, Function, and Disease Supplement ProgramU01HG008657 · NHGRI · UNIVERSITY OF WASHINGTON · PI David Russell Crosslin, Gail Pairitz Jarvik · 2015 to 2026
$13.4M
Medical Genetics Training GrantT32GM007454 · NIGMS · UNIVERSITY OF WASHINGTON · PI Gail Pairitz Jarvik, Andrew Ben Stergachis · 1985 to 2026
$6.9M
NHGRI NIH HHS U01 HG008657NIGMS NIH HHS T32 GM007454
6 · The paper itself

Abstract

backgroundGenetic testing has multigenerational and familial repercussions. However, the "trickle-down effect" of providing genetic counseling and testing to family members at risk after an initial identification of a pathogenic variant in a medically actionable gene has been poorly understood.

methodsThree probands were identified during the pharmacogenetics research phase of eMERGEII (electronic MEdical Record and Genomics, phase II) to have variants in genes associated with autosomal dominant adult-onset disorders determined to be actionable by the American College of Medical Genetics (ACMG). Two of the three probands had variants that were classified as pathogenic and the third proband had a variant ultimately classified of uncertain significance, but of concern due to the proband's own phenotype. All probands had additional family members at risk for inheriting the variant. Two of the three probands had family members who received their medical care from the same health care system, Group Health Cooperative (GHC). It was recommended that the proband contact their family members at risk to be referred to genetic counseling for consideration of genetic testing.

resultsThe two probands with pathogenic variants contacted some of their family members at risk. Individuals contacted included children and adult grandchildren, particularly if they received their medical care at GHC. To the best of our knowledge, siblings and more distant relatives at risk were not informed by the proband of their genetic risk.

conclusionsEstablishing a family network is essential to disseminate knowledge of genetic risk. These three initial cases describe our experience of contacting eMERGE participants with identified variants, providing the probands with appropriate genetic counseling and care coordination, and recommendations for contacting family members at risk. Greater challenges were observed for coordinating genetics care for family members and extending the family network to include other relatives at risk.

Indexed as

Electronic medical record and genomicsfamily networkLDLRRYR1SCN5A

Identifiers

PMID28361098
PMCPMC5370219
OpenAlexW2567567998

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.